Medicare Enrolled

Dr. Rachel Osborn, MD

Obstetrics & Gynecology · Flower Mound, TX
Low-engagement
3051 CHURCHILL DR STE 220, Flower Mound, TX 75022
2145131101
In practice since 2009 (16 years)
NPI: 1578793311 verify on NPPES ↗
High
DATA COVERAGE
Data in 3 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Dr. Osborn from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Osborn? Request a correction or review of any data shown here. Provider portal →

What this data tells you about Dr. Osborn

Dr. Rachel Osborn is an obstetrics & gynecology in Flower Mound, TX, with 16 years in practice.

Between the years covered by Open Payments, Dr. Osborn received a total of $5,195 from 50 pharmaceutical and/or device companies across 326 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in obstetrics & gynecology. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.

The Data Coverage level for Dr. Osborn is High — reflecting how much public federal data is available about this provider. This is not a quality rating. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.

✓ 16 years in practice$ $5,195 industry payments

Industry Payment Transparency

Open Payments through 2024 ↗
$5,195
Total received (2018-2024)
Avg $742/year across 7 years
Top 14% in TX for obstetrics & gynecology
50
Companies
326
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →

Payment profile

Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.

Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$5,041 (97.0%)
Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$153 (3.0%)

Payment trend by year

Annual totals from pharmaceutical and medical device companies.

2024
$839
2023
$918
2022
$826
2021
$877
2020
$643
2019
$359
2018
$732

Payments by company (2024)

Consulting
Speaking
Meals & Travel
Research
ABBVIE INC.
$495
Currax Pharmaceuticals LLC
$455
Astellas Pharma US Inc
$401
AbbVie Inc.
$393
PFIZER INC.
$282
Roche Diagnostics Corporation
$244
MILLICENT US INC
$230
AbbVie, Inc.
$199
MAYNE PHARMA INC.
$193
Allergan Inc.
$188
SHIELD THERAPEUTICS INC
$156
MAYNE PHARMA COMMERCIAL LLC
$132
Endo Pharmaceuticals Inc.
$131
Organon LLC
$122
Novo Nordisk Inc
$115
VIVUS, Inc.
$112
TherapeuticsMD, Inc.
$89
Exeltis, USA Inc.
$76
Organon Llc
$71
IDORSIA PHARMACEUTICALS US INC
$71
Avion Pharmaceuticals
$69
AMAG Pharmaceuticals, Inc.
$68
CooperSurgical, Inc.
$67
Allergan, Inc.
$67
Sumitomo Pharma America, Inc.
$62
Virtus Pharmaceuticals LLC
$60
Biogen, Inc.
$57
Agile Therapeutics, Inc.
$47
Duchesnay USA Incorporated
$44
Merck Sharp & Dohme Corporation
$41
Myriad Women's Health, Inc.
$36
Bayer HealthCare Pharmaceuticals Inc.
$35
Avanos Medical
$33
Mylan Pharmaceuticals Inc.
$32
Takeda Pharmaceuticals U.S.A., Inc.
$31
Evofem Biosciences, Inc.
$29
Salix Pharmaceuticals, a division of Bausch Health US, LLC
$27
Nalpropion Pharmaceuticals, Inc.
$27
Lupin Inc.
$24
Shield Therapeutics Inc
$23
Hologic, LLC
$23
Bayer Healthcare Pharmaceuticals Inc.
$20
Mycovia Pharmaceuticals, Inc.
$20
VIVUS LLC
$18
Boston Scientific Corporation
$17
Merck Sharp & Dohme LLC
$14
Eisai Inc.
$14
EISAI INC.
$13
Orexigen Therapeutics, Inc.
$11
Mission Pharmacal Company
$9
Top 3 companies account for 26.0% of total payments
Associated products mentioned in payments ›
ACCRUFER · ANNOVERA · BELSOMRA · BIJUVA · Balcoltra · Belviq · CITRANATAL MEDLEY · CONTRAVE · Divigel · FEMRING · Femring · IMVEXXY · INTRAROSA · JADA SYSTEM · Kyleena · LILETTA · LO LOESTRIN FE · Lupron · MAKENA · MYFEMBREE · MYRISK · Mirena · Myrbetriq · NASCOBAL · NEXPLANON · Novasure · ON-Q* PUMP AND ACCESSORIES · ONZETRA XSAIL · ORIAHNN · ORILISSA · Orilissa · Osphena · PREMARIN · PREMARIN ORALS · PROMETRIUM · Paragard · Phexxi · QSYMIA · QUVIVIQ · Qsymia · RS Harmony Test Related Products · SLYND · SOLOSEC · SYMPHION · Saxenda · Trintellix · Twirla · VUMERITY · Veozah · Vitafol Ultra · Vivjoa · Wegovy · XIFAXAN · Xulane
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →

Most payments (97%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians.

Looking for a obstetrics & gynecology in Flower Mound?
Compare obstetrics & gynecologys in the Flower Mound area by procedure volume, costs, and industry payment transparency.
Browse obstetrics & gynecologys nearby

Geographic Context

Obstetrics & Gynecologys within 10 mi
679
Per 100K population
71.8
County median income
$108,185
Nearest hospital
TEXAS HEALTH PRESBYTERIAN HOSPITAL FLOWER MOUND
3.2 mi

Data Sources

Provider Registry NPPESWeekly updates
Medicare Enrollment PECOSMonthly updates
Practice Data— No dataN/A
Industry Payments Open PaymentsCY 2024
Disciplinary History— Not publicN/A

This provider has data in 3 of 4 available federal datasets, with a Data Coverage level of High. This measures how much public data is available about a provider — not how good they are. How we calculate this →

Summary

Dr. Osborn is a obstetrics & gynecology, and high industry engagement (low-engagement, top 14%), with 16 years of practice experience.

This summary is auto-generated from federal data. It describes data availability and patterns — not clinical quality. Read our methodology →

Frequently Asked Questions

Does Dr. Osborn receive payments from pharmaceutical companies?
Yes. Dr. Osborn received a total of $5,195 from 50 companies across 326 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
What does Data Coverage mean?
Data Coverage (currently High for Dr. Osborn) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
About this page

All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.

This page is not medical advice, an endorsement, a recommendation, or a quality rating. The Transparency Score measures data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.

Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology

Data Disclaimer — Data sourced from the Centers for Medicare & Medicaid Services (CMS): National Plan and Provider Enumeration System (NPPES), Open Payments program, Medicare Provider Utilization and Payment Data, and Provider Enrollment & Certification data (PECOS). Published under the Freedom of Information Act (FOIA). This website is not affiliated with, endorsed by, or authorized by CMS, HHS, or the U.S. Government. Data may contain errors as reported to CMS by providers and reporting entities. Payments from industry are legal and do not indicate wrongdoing. Medicare data reflects only patients aged 65+ or those with qualifying disabilities. For corrections, contact CMS directly. This information does not constitute medical advice and should not be used as the sole basis for choosing a healthcare provider. Procedure descriptions use plain language and do not reference CPT® codes, which are copyrighted by the American Medical Association. Full methodology → · Report a data error → · Privacy policy →